Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Legal Officer

Chief Business Officer

Chief Product Strategy Officer

President and CEO

Chief Fin. & Admin Officer

Chief Scientific Officer

Chief Medical Officer

Sr. VP, New Prod. Strat. & Dev

Sr. VP, Finance & Admin. & CFO

Sr. VP, Business Dev.

Sr. VP & CMO

Sr. VP, R&D & CSO

Sr. VP & General Counsel

Sr. VP & CSO

Treasurer and CFO

Sr. VP, New Product Dev.

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and license agreement with Abbott Laboratories to identify, develop, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir for the treatment of chronic hepatitis C virus. Enanta Pharmaceuticals, Inc. was founded in 1995 and is headquartered in Watertown, Massachusetts.

Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections a...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-02-26	Premium	acquired	Premium	Premium	Premium	Chief Legal Officer
2024-02-12	Premium	sold (taxes)	Premium	Premium	Premium	Chief Business Officer
2024-02-12	Premium	acquired	Premium	Premium	Premium	Chief Product Strategy Officer
2024-02-12	Premium	sold (taxes)	Premium	Premium	Premium	President and CEO
2024-02-12	Premium	sold (taxes)	Premium	Premium	Premium	Chief Fin. & Admin Officer
2024-02-12	Premium	sold (taxes)	Premium	Premium	Premium	Chief Legal Officer
2024-02-12	Premium	acquired	Premium	Premium	Premium	President and CEO
2024-02-12	Premium	acquired	Premium	Premium	Premium	Chief Business Officer
2024-02-12	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2024-02-12	Premium	acquired	Premium	Premium	Premium	Chief Legal Officer
2024-02-12	Premium	sold (taxes)	Premium	Premium	Premium	Chief Scientific Officer
2024-02-12	Premium	acquired	Premium	Premium	Premium	Chief Fin. & Admin Officer
2024-02-12	Premium	sold (taxes)	Premium	Premium	Premium	Chief Medical Officer
2024-02-12	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2024-02-12	Premium	sold (taxes)	Premium	Premium	Premium	Chief Product Strategy Officer
2023-12-13	Premium	sold	Premium	Premium	Premium	-
2023-12-05	Premium	sold	Premium	Premium	Premium	Sr. VP, New Prod. Strat. & Dev
2023-12-05	Premium	sold	Premium	Premium	Premium	Sr. VP, Finance & Admin. & CFO
2023-12-05	Premium	sold	Premium	Premium	Premium	President and CEO
2023-12-05	Premium	sold	Premium	Premium	Premium	Sr. VP, Business Dev.
2023-12-05	Premium	sold	Premium	Premium	Premium	Sr. VP & CMO
2023-12-05	Premium	sold	Premium	Premium	Premium	Sr. VP, R&D & CSO
2023-12-05	Premium	sold	Premium	Premium	Premium	Sr. VP & General Counsel
2023-12-01	Premium	sold (taxes)	Premium	Premium	Premium	Sr. VP, Finance & Admin. & CFO
2023-12-01	Premium	sold (taxes)	Premium	Premium	Premium	Sr. VP, R&D & CSO

ENTA - Enanta Pharmaceuticals Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for ENTA